F13.96 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder

Name of the Condition

• Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder

Summary

This condition involves the use of sedative, hypnotic, or anxiolytic substances with a concurrent persisting amnestic disorder caused by these drugs. The unspecified nature of the use indicates insufficient detail to classify the pattern of use further, while the amnestic disorder reflects persistent memory impairment resulting from substance exposure. These substances are commonly prescribed for anxiety, insomnia, or sedation but may be used in ways that do not meet criteria for a more specific disorder.

Causes

The condition arises from the use of sedative, hypnotic, or anxiolytic drugs, such as benzodiazepines or barbiturates. The persisting amnestic disorder is a direct result of the substance's effects on the central nervous system, leading to long-term memory deficits. Use may be prescribed or non-medical, and the unspecified nature indicates insufficient detail to classify the pattern of use beyond the presence of the amnestic disorder.

Risk Factors

• Prolonged or excessive use of these medications
• History of substance use disorders
• Underlying mental health conditions (e.g., anxiety, depression)
• Easy access to sedative/hypnotic/anxiolytic drugs
• Recreational or non-medical use

Symptoms

• Use of sedative, hypnotic, or anxiolytic substances
• Persistent memory impairment (e.g., difficulty recalling recent events or forming new memories)
• No evidence of dependence, withdrawal, or abuse beyond the amnestic disorder
• No associated medical or psychiatric complications other than the amnestic disorder

Diagnosis

Diagnosis is based on clinical evaluation of substance use history and assessment of the pattern of use. The presence of a persisting amnestic disorder directly attributable to sedative, hypnotic, or anxiolytic use is key. The unspecified nature of the use indicates that criteria for a more specific disorder (e.g., abuse, dependence) are not met or documented. Neurological or neuropsychological testing may be used to confirm memory deficits.

Treatment Options

• Addressing the underlying substance use (e.g., tapering or discontinuing the drug)
• Cognitive rehabilitation to manage memory impairment
• Monitoring for potential misuse or dependence
• Supportive care for daily functioning and safety

Prognosis and Follow-Up

Prognosis depends on the severity of the amnestic disorder and the ability to reduce or eliminate substance use. Some memory deficits may be reversible with cessation of the drug, while others may persist. Regular follow-up is necessary to monitor cognitive function and substance use patterns.

Complications

• Persistent memory impairment affecting daily life
• Increased risk of accidents or injuries due to memory deficits
• Potential for ongoing substance use leading to further complications

Lifestyle & Prevention

• Avoiding non-medical use of sedative, hypnotic, or anxiolytic drugs
• Using these medications only as prescribed and under medical supervision
• Seeking alternative treatments for anxiety or insomnia when possible
• Educating patients on the risks of long-term use

When to Seek Professional Help

Seek help if you or someone you know experiences persistent memory problems after using sedative, hypnotic, or anxiolytic drugs, or if substance use is interfering with daily functioning.

Tips for Medical Coders

This code requires documentation of both the unspecified use of sedative, hypnotic, or anxiolytic substances and the presence of a sedative, hypnotic, or anxiolytic-induced persisting amnestic disorder. Ensure the medical record clearly links the amnestic disorder to the substance use. The unspecified nature of the use indicates that no further detail about the pattern of use (e.g., abuse, dependence) is documented or applicable.